Letter | Published:

Coronin 2A mediates actin-dependent de-repression of inflammatory response genes

Nature volume 470, pages 414418 (17 February 2011) | Download Citation

Abstract

Toll-like receptors (TLRs) function as initiators of inflammation through their ability to sense pathogen-associated molecular patterns and products of tissue damage1,2. Transcriptional activation of many TLR-responsive genes requires an initial de-repression step in which nuclear receptor co-repressor (NCoR) complexes are actively removed from the promoters of target genes to relieve basal repression3,4. Ligand-dependent SUMOylation of liver X receptors (LXRs) has been found to suppress TLR4-induced transcription potently by preventing the NCoR clearance step5,6,7, but the underlying mechanisms remain enigmatic. Here we provide evidence that coronin 2A (CORO2A), a component of the NCoR complex of previously unknown function8,9, mediates TLR-induced NCoR turnover by a mechanism involving interaction with oligomeric nuclear actin. SUMOylated LXRs block NCoR turnover by binding to a conserved SUMO2/SUMO3-interaction motif in CORO2A and preventing actin recruitment. Intriguingly, the LXR transrepression pathway can itself be inactivated by inflammatory signals that induce calcium/calmodulin-dependent protein kinase IIγ (CaMKIIγ)-dependent phosphorylation of LXRs, leading to their deSUMOylation by the SUMO protease SENP3 and release from CORO2A. These findings uncover a CORO2A–actin-dependent mechanism for the de-repression of inflammatory response genes that can be differentially regulated by phosphorylation and by nuclear receptor signalling pathways that control immunity and homeostasis.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Transcriptional control of the inflammatory response. Nature Rev. Immunol. 9, 692–703 (2009)

  2. 2.

    TLRs and innate immunity. Blood 113, 1399–1407 (2009)

  3. 3.

    et al. A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation. Proc. Natl Acad. Sci. USA 101, 14461–14466 (2004)

  4. 4.

    et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature 437, 759–763 (2005)

  5. 5.

    et al. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARγ. Mol. Cell 25, 57–70 (2007)

  6. 6.

    et al. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor. Circ. Res. 99, e88–e99 (2006)

  7. 7.

    et al. GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRβ in the hepatic acute phase response. Genes Dev. 24, 381–395 (2010)

  8. 8.

    et al. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22, 1336–1346 (2003)

  9. 9.

    et al. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol. Cell 12, 723–734 (2003)

  10. 10.

    et al. Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex. Mol. Cell 34, 145–154 (2009)

  11. 11.

    et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10, R130 (2009)

  12. 12.

    et al. Expression analysis of G protein-coupled receptors in mouse macrophages. Immunome Res. 4, 5 (2008)

  13. 13.

    & Coronins: the return of the crown. Trends Cell Biol. 16, 421–426 (2006)

  14. 14.

    , , & Coronin switches roles in actin disassembly depending on the nucleotide state of actin. Mol. Cell 34, 364–374 (2009)

  15. 15.

    et al. Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes Dev. 23, 681–693 (2009)

  16. 16.

    et al. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 122, 707–721 (2005)

  17. 17.

    , & Actin up in the nucleus. Nature Rev. Mol. Cell Biol. 5, 410–415 (2004)

  18. 18.

    , & The crystal structure of murine coronin-1: a regulator of actin cytoskeletal dynamics in lymphocytes. Structure 14, 87–96 (2006)

  19. 19.

    , & Functional surfaces on the actin-binding protein coronin revealed by systematic mutagenesis. J. Biol. Chem. 285, 34899–34908 (2010)

  20. 20.

    et al. Conformational difference between nuclear and cytoplasmic actin as detected by a monoclonal antibody. J. Cell Sci. 112, 797–809 (1999)

  21. 21.

    et al. Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint. Mol. Cell 35, 48–57 (2009)

  22. 22.

    et al. Actin-latrunculin A structure and function. Differential modulation of actin-binding protein function by latrunculin A. J. Biol. Chem. 275, 28120–28127 (2000)

  23. 23.

    et al. Salmonella typhimurium induces epithelial IL-8 expression via Ca2+-mediated activation of the NF-κB pathway. J. Clin. Invest. 105, 79–92 (2000)

  24. 24.

    , , & Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 102, 328–335 (2003)

  25. 25.

    et al. Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc. Natl Acad. Sci. USA 105, 19199–19204 (2008)

  26. 26.

    et al. An oestrogen-receptor-α-bound human chromatin interactome. Nature 462, 58–64 (2009)

  27. 27.

    , , & Rapid actin monomer-insensitive depolymerization of Listeria actin comet tails by cofilin, coronin, and Aip1. J. Cell Biol. 175, 315–324 (2006)

  28. 28.

    et al. Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47phox: complement, leukotrienes, and reactive oxidants in acute inflammation. J. Leukoc. Biol. 71, 410–416 (2002)

  29. 29.

    et al. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells. Clin. Cancer Res. 12, 4055–4061 (2006)

  30. 30.

    et al. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 458, 1180–1184 (2009)

Download references

Acknowledgements

We thank S. Amano for preparation of GeRP delivery spheres. We thank L. Bautista for assistance with preparation of the manuscript. W.H. was supported by NRSA 1F31DK083913. These studies were supported by National Institutes of Health grants CA52599, DK074868, HC088093 and DK085853 and a Leducq Foundation Transatlantic Network Grant. M.G.R. is an investigator of the Howard Hughes Medical Institute.

Author information

Author notes

    • Serena Ghisletti

    Present address: Department of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy.

Affiliations

  1. Department of Cellular and Molecular Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0651, USA

    • Wendy Huang
    • , Serena Ghisletti
    • , Kaoru Saijo
    • , Dawn X. Zhang
    • , Joyee Yao
    •  & Christopher K. Glass
  2. Biomedical Sciences Graduate Program, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0651, USA

    • Wendy Huang
    •  & Dawn X. Zhang
  3. Department of Biology, Rosenstiel Basic Medical Science Research Center, Brandeis University, Waltham, Massachusetts 02454, USA

    • Meghal Gandhi
    •  & Bruce L. Goode
  4. Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, Massachusetts 01605, USA

    • Myriam Aouadi
    • , Greg J. Tesz
    •  & Michael P. Czech
  5. Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0651, USA

    • Michael G. Rosenfeld
    •  & Christopher K. Glass
  6. Howard Hughes Medical Institute, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0651, USA

    • Michael G. Rosenfeld

Authors

  1. Search for Wendy Huang in:

  2. Search for Serena Ghisletti in:

  3. Search for Kaoru Saijo in:

  4. Search for Meghal Gandhi in:

  5. Search for Myriam Aouadi in:

  6. Search for Greg J. Tesz in:

  7. Search for Dawn X. Zhang in:

  8. Search for Joyee Yao in:

  9. Search for Michael P. Czech in:

  10. Search for Bruce L. Goode in:

  11. Search for Michael G. Rosenfeld in:

  12. Search for Christopher K. Glass in:

Contributions

W.H., S.G., K.S., M.C., B.L.G., M.G.R. and C.K.G. conceived the project and planned experiments and analysis, which were performed by W.H., S.G., K.S., M.G., M.A., G.T., D.Z. and J.Y. The entire project was supervised by C.K.G., who wrote the manuscript with W.H.

Competing interests

M.P.C. is a consultant to, and an equity holder in, RXi Pharmaceuticals, which has licensed the GeRP siRNA delivery method.

Corresponding author

Correspondence to Christopher K. Glass.

Supplementary information

PDF files

  1. 1.

    Supplementary Figures

    This file contains Supplementary Figures 1-10 with legends.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nature09703

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.